The increasing complexity of cancer treatment necessitates a thorough understanding of varied healthcare systems. This article aims to investigate the strengths and limitations of transatlantic cancer care, evaluating the treatment protocols in both the United States and Europe. Through a multifaceted lens, we will examine key variables, including